IDS (Immuno Diagnostic Systems)

  Immunodiagnostic Systems Holdings PLC (hereafter referred to as IDS) is a leading in-vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture, and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.    IDS was founded in 1977 and trades on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. We are a global company headquartered in the UK with around 350 employees worldwide. Our products are developed and manufactured at our facilities in Europe. We serve our customers through regional offices in Europe, the USA and Brazil. Our network of distributors work on our behalf to serve our customers throughout the rest of the world.